These results suggest that the NT5DC3 mRNA and protein levels are a bona fide biomarker in distinguishing healthy volunteers and T2D patients, and even T2D/colon cancer coexistence patients. The gene discussed is NT5DC3; the disease is malignant colon neoplasm.